Correlation Between Flowr Corp and Cannara Biotech

Can any of the company-specific risk be diversified away by investing in both Flowr Corp and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Flowr Corp and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Flowr Corp and Cannara Biotech, you can compare the effects of market volatilities on Flowr Corp and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Flowr Corp with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Flowr Corp and Cannara Biotech.

Diversification Opportunities for Flowr Corp and Cannara Biotech

0.0

Correlation Coefficient

Flowr Corp  Cannara Biotech

Pay attention - limited upside

The 3 months correlation between Flowr and Cannara is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Flowr Corp and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Flowr Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Flowr Corp are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Flowr Corp i.e., Flowr Corp and Cannara Biotech go up and down completely randomly.

Pair Corralation between Flowr Corp and Cannara Biotech

Assuming the 90 days horizon Flowr Corp is expected to generate 21.99 times more return on investment than Cannara Biotech. However, Flowr Corp is 21.99 times more volatile than Cannara Biotech. It trades about 0.08 of its potential returns per unit of risk. Cannara Biotech is currently generating about 0.01 per unit of risk. If you would invest  1.90  in Flowr Corp on September 29, 2024 and sell it today you would lose (1.90) from holding Flowr Corp or give up 100.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	82.66%
Values	Daily Returns

Flowr Corp  vs.  Cannara Biotech

Flowr Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Flowr Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Flowr Corp is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Cannara Biotech

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent technical and fundamental indicators, Cannara Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Flowr Corp and Cannara Biotech

The main advantage of trading using opposite Flowr Corp and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Flowr Corp position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.

The idea behind Flowr Corp and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.